US FDA to convene expert panel to review wider access to some peptides Reuters BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with BPC 157 for athletes and injury treatment: Science, safety, and legal concerns BPC 157 Banned: Key Facts on the Latest FDA Decision